COVID-19 caused by the novel SARS-CoV-2 has been declared a pandemic by the WHO is
causing havoc across the entire world. As of May end, about 6 million people have been …

The SARS-CoV-2 pandemic has prompted scientists from many disciplines to work
collaboratively toward an effective response. As academic synthetic chemists, we examine …

The ongoing COVID-19 pandemic has resulted in millions of deaths globally, highlighting
the need to develop potent prophylactic and therapeutic strategies against SARS-CoV-2 …

The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in December 2019 and has …

The SARS-CoV-2 pandemic, declared as a global health emergency by the WHO in
February 2020, has currently infected more than 6 million people with fatalities near 371,000 …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide,
particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals …

While we currently have multiple highly effective vaccines approved for use against SARS-
CoV-2 in the USA and other countries, there are far fewer small molecule antivirals …

SARS-CoV-2 has been widely spread around the world and COVID-19 was declared a
global pandemic by the WHO. Limited clinically effective antiviral drugs are available now …

In December 2019, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-
related epidemic was first observed in Wuhan, China. In 2020, owing to the highly infectious …